Celgene's future seems to be a big question mark

Discussion in 'Celgene' started by anonymous, Oct 26, 2017 at 9:26 AM.

  1. anonymous

    anonymous Guest

    http://alphastreet.com/b0662389 Celgene's outlook, especially it's long-term targets, is not an encouraging one. Also, a decrease in pharma company's research and development expenses is not a good sign.
     

  2. anonymous

    anonymous Guest

    I can MA has done a great job running the company in the ground. What an A hole
     
  3. anonymous

    anonymous Guest

    What was the board of directors up to? Can’t blame just one person
     
  4. anonymous

    anonymous Guest

    He is an ego maniac who cares about nothing but himslef
     
  5. anonymous

    anonymous Guest

    So what’s the plan? Can’t see Celgene letting the company hit rock bottom, not at all.
     
  6. anonymous

    anonymous Guest

    Yikes! Got a call from a recruiter recently about an opening with Celgene. Glad I didn't call them back now!
     
  7. anonymous

    anonymous Guest

    You should be so lucky liar!!
     
  8. anonymous

    anonymous Guest

    I was actually not lying. I am not looking to leave my current position, and so I felt no need to call the recruiter back. And after reading about Celgene woes, and your idiotic "personality" I am grateful I didn't .
     
  9. anonymous

    anonymous Guest

    Was it for the Sr. Ball Drainer opening? Lucrative
     
  10. anonymous

    anonymous Guest

    Exactly what he did for Sanofi. I wouldn't be surprised if he shorted the stock a month ago.
     
  11. anonymous

    anonymous Guest

    Is there any hope for the stock? Not recovering. falling falling failing!
     
  12. anonymous

    anonymous Guest

    we are too!
     
  13. anonymous

    anonymous Guest

    Seems to be doing a little better. Opinions on upcoming ASH effect?
     
  14. anonymous

    anonymous Guest

    ASH effect? HAHAHAHA! What do you have that is new? Another bullshit abstract on why you continue to delay rev lymphoma indication? Another bullshit excuse on why you are still so heavily dependent on the revenue of just one drug? Oh,oh, I know....that whopping increase in sales from a pancreatic indication with Abraxane? Oh, my bad....still a sore spot.

    MA got his stock sold before the big sell off. Why didn't you?
     
  15. anonymous

    anonymous Guest



    MA got his stock sold before the big sell off.
    Sounds like insider information & trading?
     
  16. anonymous

    anonymous Guest

    What a surprise. He walks away with big money and gets his options replenished. All for one and one for MA.
     
  17. anonymous

    anonymous Guest

    Unethical! Needs to be investigated.
     
  18. anonymous

    anonymous Guest

    Abraxane is a 1 billion dollar + product! It pays the bills!
     
  19. anonymous

    anonymous Guest

    Many WS analyst reports indicate it’s declining.
     
  20. anonymous

    anonymous Guest

    why is the stock price so low?